GlaxoSmithKline Pharma's Q1FY17 declines 22% to Rs 38 crore
It’s operating profit (EBITDA – earnings before interest tax depreciation and tax) stood at Rs 90.35, recording drop of 18.69% yoy and 29.91% qoq. While the company’s OPM (operating profit margin) was at 12.80%, contracting by 424 bps yoy and 544 bps qoq.
The companys net profit of Rs 38.55 crore, registered decline of 22.41% yoy and 31.62% qoq. Photo: Pixabay